In The News

In Bloomberg Law, IP Litigators Analyze Potential Hurdles to U.S. Implementation of a COVID-19-Related IP Rights Waiver

Practices: Intellectual Property, Intellectual Property Litigation, Patent Strategy, Litigation, Administrative Litigation, Life Sciences, Health Care, Biomedical Research: Human, Animal and Bench Science

As the World Trade Organization continues to debate a global waiver of intellectual property rights to combat the COVID-19 pandemic, IP litigation partner Matt Rizzolo and associate Kathryn Thornton (both of Washington, D.C.) analyzed some of the Constitutional and administrative hurdles the US government may face in implementing any such waiver in a Bloomberg Law article.

Cookie Settings